UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model

International journal of oncology, 2014-01, Vol.44 (1), p.147-152

2014

Volltextzugriff (PDF)

Formulation and characterization of EGCG for the treatment of superficial bladder cancer

International journal of molecular medicine, 2017-08, Vol.40 (2), p.329-336

2017

Volltextzugriff (PDF)

A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model

The Journal of urology, 2011-08, Vol.186 (2), p.702-706

2011

Volltextzugriff (PDF)

Synergistic anticancer activity of biologicals from green and black tea on DU 145 human prostate cancer cells

Central-European journal of immunology, 2015, Vol.40 (1), p.1-4

2015

Volltextzugriff (PDF)

In vivo and in vitro effect of baicalein on human prostate cancer cells

International journal of oncology, 2005-01, Vol.26 (1), p.241

2005

Volltextzugriff (PDF)

Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate

The Journal of urology, 2003-09, Vol.170 (3), p.773-776

2003

Volltextzugriff (PDF)

Very long half‐life plasminogen activator inhibitor type 1 reduces bleeding in a mouse model

BJU international, 2010-05, Vol.105 (10), p.1469-1476

2010

Volltextzugriff (PDF)

Prevention and treatment of transitional cell carcinomatosis with intraperitoneal chemotherapy in a rat model

The Journal of urology, 2009-04, Vol.181 (4), p.1901-1906

2009

Volltextzugriff (PDF)

Prostatic involution after intraprostatic injection of cobra toxin

The Journal of urology, 2010-11, Vol.184 (5), p.2192-2196

2010

Volltextzugriff (PDF)

Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy

BJU international, 2005-06, Vol.95 (9), p.1237-1244

2005

Volltextzugriff (PDF)

PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells

International journal of molecular medicine, 2007-07, Vol.20 (1), p.11-20

2007

Volltextzugriff (PDF)

Intraperitoneal chemotherapy for the prevention of transitional cell carcinoma implantation

The Journal of urology, 2006-06, Vol.175 (6), p.2317-2322

2006

Volltextzugriff (PDF)

Experimental immunology Synergistic anticancer activity of biologicals from green and black tea on DU 145 human prostate cancer cells

Central-European journal of immunology, 2015, Vol.1, p.1-4

2015

Volltextzugriff (PDF)

Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy

The Journal of urology, 2004-08, Vol.172 (2), p.739-743

2004

Volltextzugriff (PDF)

Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate

The Journal of urology, 2001-05, Vol.165 (5), p.1795-1801

2001

Volltextzugriff (PDF)

MP37-15 APPLICATION OF LONG-ACTING PAI-1 DURING SUTURELESS PARTIAL NEPHRECTOMY IN MICE

The Journal of urology, 2014-04, Vol.191 (4S)

2014

Volltextzugriff (PDF)

Replacement of intestinal mucosa with urothelium in rat augmented bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid

The Journal of urology, 2007-09, Vol.178 (3 Pt 1), p.1108-1112

2007

Volltextzugriff (PDF)

Use of small intestinal submucosa for corporal body grafting in cases of severe penile curvature

The Journal of urology, 2002-10, Vol.168 (4 Pt 2), p.1742-1745

2002

Volltextzugriff (PDF)

Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT

Physics in medicine & biology, 2004-07, Vol.49 (14), p.3209-3225

2004

Volltextzugriff (PDF)

Application of Long-Acting VLHL PAI-1 during Sutureless Partial Nephrectomy in Mice Reduces Bleeding

BioMed research international, 2015-01, Vol.2015 (2015), p.1-7

2015

Volltextzugriff (PDF)

Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice

Oncology reports, 2001-05, Vol.8 (3), p.463

2001

Volltextzugriff (PDF)

Comparison between the clot-protecting activity of a mutant plasminogen activator inhibitor-1 with a very long half-life and 6-aminocaproic acid

Experimental and therapeutic medicine, 2015-06, Vol.9 (6), p.2339-2343

2015

Volltextzugriff (PDF)

Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives

Oncology letters, 2014-01, Vol.7 (1), p.17-22

2014

Volltextzugriff (PDF)

Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss

International journal of molecular medicine, 2010-10, Vol.26 (4), p.501-504

2010

Volltextzugriff (PDF)

New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors

Cancer research (Chicago, Ill.), 1988, Vol.48 (1), p.194-198

1988

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(81)
Tagungsberichte
(1)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Animals
(52)
Life Sciences & Biomedicine
(52)
Biological And Medical Sciences
(36)
Rats
(34)
Medical Sciences
(31)
Male
(30)
Rats, Inbred F344
(26)
Urology & Nephrology
(22)
Photochemotherapy
(21)
Urinary Bladder Neoplasms - Drug Therapy
(16)
Humans
(13)
Nephrology. Urinary Tract Diseases
(12)
Mice
(11)
Porphyrins - Therapeutic Use
(11)
Oncology
(10)
Tumors
(10)
Dose-Response Relationship, Drug
(9)
Neoplasm Transplantation
(8)
Prostate
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model

Formulation and characterization of EGCG for the treatment of superficial bladder cancer

A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model

Synergistic anticancer activity of biologicals from green and black tea on DU 145 human prostate cancer cells

In vivo and in vitro effect of baicalein on human prostate cancer cells

Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate

Very long half‐life plasminogen activator inhibitor type 1 reduces bleeding in a mouse model

Prevention and treatment of transitional cell carcinomatosis with intraperitoneal chemotherapy in a rat model

Prostatic involution after intraprostatic injection of cobra toxin

Diverse optical characteristic of the prostate and light delivery system: implications for computer modelling of prostatic photodynamic therapy

PAI-1 induces cell detachment, downregulates nucleophosmin (B23) and fortilin (TCTP) in LnCAP prostate cancer cells

Intraperitoneal chemotherapy for the prevention of transitional cell carcinoma implantation

Experimental immunology Synergistic anticancer activity of biologicals from green and black tea on DU 145 human prostate cancer cells

Optical characteristics of the canine prostate at 665 nm sensitized with tin etiopurpurin dichloride: need for real-time monitoring of photodynamic therapy

Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate

MP37-15 APPLICATION OF LONG-ACTING PAI-1 DURING SUTURELESS PARTIAL NEPHRECTOMY IN MICE

Replacement of intestinal mucosa with urothelium in rat augmented bladders using intravesical photodynamic therapy with 5-aminolaevulinic acid

Use of small intestinal submucosa for corporal body grafting in cases of severe penile curvature

Transperineal in vivo fluence-rate dosimetry in the canine prostate during SnET2-mediated PDT

Application of Long-Acting VLHL PAI-1 during Sutureless Partial Nephrectomy in Mice Reduces Bleeding

Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice

Comparison between the clot-protecting activity of a mutant plasminogen activator inhibitor-1 with a very long half-life and 6-aminocaproic acid

Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivatives

Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss

New photosensitizers for photodynamic therapy: combined effect of metallopurpurin derivatives and light on transplantable bladder tumors

Suchergebnisse filtern